Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 700,966 | 674,978 | 666,823 | 541,533 | 429,647 |
| Cost of Goods | 170,428 | 184,669 | 199,295 | 140,255 | 117,328 |
| Gross Profit | 530,538 | 490,309 | 467,528 | 401,278 | 312,319 |
| Operating Expenses | 604,337 | 403,303 | 407,799 | 311,609 | 266,297 |
| Operating Income | -73,371 | 87,675 | 60,024 | 89,924 | 46,350 |
| Interest Expense | 16,569 | 20,306 | 39,976 | 31,750 | 25,671 |
| Other Income | 26,834 | -5,668 | -6,746 | -1,770 | -590 |
| Pre-tax Income | -63,106 | 61,701 | 13,302 | 56,404 | 20,089 |
| Income Tax | 36,454 | 19,746 | -2,607 | 14,424 | -125,434 |
| Net Income Continuous | -99,560 | 41,955 | 15,909 | 41,980 | 145,523 |
| Net Income | $-99,560 | $41,955 | $15,909 | $41,980 | $145,523 |
| EPS Basic Total Ops | -2.15 | 0.91 | 0.35 | 0.95 | 3.41 |
| EPS Basic Continuous Ops | -2.15 | 0.91 | 0.35 | 0.95 | 3.41 |
| EPS Diluted Total Ops | -2.15 | 0.89 | 0.34 | 0.92 | 3.33 |
| EPS Diluted Continuous Ops | -2.15 | 0.81 | 0.34 | 0.92 | 3.33 |
| EPS Diluted Before Non-Recurring Items | 2.34 | 2.09 | 1.84 | 2.26 | 1.30 |
| EBITDA(a) | $8,636 | $166,997 | $158,732 | $144,378 | $86,668 |